
ABOUT IQVIA INTEGRATED GLOBAL COMPLIANCE
IQVIA Integrated Global Compliance offers a complete lifecycle approach that brings together safety, regulatory, quality, and medical information to transform how life sciences companies sustain compliance and how compliance functions perform better together.
By integrating services, technology, and analytics, we can help bring together disparate compliance functions, resulting in heightened patient safety, improved compliance performance, and proactive insights power by IQVIA Connected Intelligence.
Learn more about IQVIA’s Integrated Global Compliance at https://www.iqvia.com/solutions/integrated-global-compliance
FEATURED SOLUTIONS
-
Discover how offering sponsors end-to-end strategic drug development and technology-enabled regulatory services help reduce time, cost, and risk, from discovery through post-registration.
-
Support your local safety needs and drive consistency with global requirements through end-to-end solutions with regulatory-focused medical experts and leading technologies.
-
Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.
-
As one of the world's largest and most experienced safety and pharmacovigilance (PV) organizations, IQVIA brings extensive domain expertise and deep regulatory intelligence to every engagement.
-
IQVIA offers a complete approach that brings together safety, regulatory, quality, and medical information to transform how life sciences companies sustain compliance and how compliance functions perform better together.
CONTACT INFORMATION
IQVIA Integrated Global Compliance
4820 Emperor Blvd.
Durham, NC 27703
UNITED STATES
FEATURED CONTENT
-
A strong labeling team is vital to ensure successful navigation of the legal entity change process, including developing a timeline, executing data transfers, and mitigating compliance risks.
-
Best Practices: Establishing An Endpoint Adjudication Committee And Key Endpoint Management Strategy
In complying with regulations, trial sponsors may need expert guidance on best practices for developing an EAC and overall strategy and oversight of key endpoint objectives and processes.
-
Managing local pharmacovigilance and medical information is no easy feat, but a local QPPV, a regulatory intelligence database, and innovative AI technology might be the solutions you are searching for.
-
Business continuity planning (BCP) ahead of the next pandemic or natural disaster is essential to ensure the success of any enterprise, but it's particularly crucial for companies in the life science industry.
-
Global biopharma companies are constantly looking for ways to increase awareness and engage health care professionals (HCPs) seeking medical information. Explore why many see artificial intelligence (AI) as a big part of the solution.
-
When patients couldn't reach their physicians during the pandemic, they turned to pharma companies for information, signaling an evolution in the engagement between consumers and healthcare brands.
-
In this white paper, discover how medical information organizations are redefining how people and AI can work together to rapidly respond to the surge in customer requests.
-
The move to digital-first for medical information offers life sciences companies a way to exceed customer expectations with technology that enables real-time, faster and more satisfying interactions.
-
If a medicine’s sponsor wants to maximize the impact of a product on patients, providers, and their own bottom line, the need to proactively make regulatory affairs part of the lifecycle planning strategy is critical to the planning process.